- Home
- HIO vs NPCE Comparison
HIO vs NPCE Comparison
Compare HIO & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- NPCE
- Stock Information
- Founded
- HIO 1993
- NPCE 1997
- Country
- HIO United States
- NPCE United States
- Employees
- HIO N/A
- NPCE N/A
- Industry
- HIO Finance/Investors Services
- NPCE Medical Specialities
- Sector
- HIO Finance
- NPCE Health Care
- Exchange
- HIO Nasdaq
- NPCE Nasdaq
- Market Cap
- HIO 380.4M
- NPCE 424.1M
- IPO Year
- HIO N/A
- NPCE 2021
- Fundamental
- Price
- HIO $3.98
- NPCE $9.07
- Analyst Decision
- HIO
- NPCE Strong Buy
- Analyst Count
- HIO 0
- NPCE 6
- Target Price
- HIO N/A
- NPCE $16.33
- AVG Volume (30 Days)
- HIO 305.3K
- NPCE 370.2K
- Earning Date
- HIO 01-01-0001
- NPCE 08-12-2025
- Dividend Yield
- HIO 10.33%
- NPCE N/A
- EPS Growth
- HIO N/A
- NPCE N/A
- EPS
- HIO N/A
- NPCE N/A
- Revenue
- HIO N/A
- NPCE $84,306,000.00
- Revenue This Year
- HIO N/A
- NPCE $21.04
- Revenue Next Year
- HIO N/A
- NPCE $10.73
- P/E Ratio
- HIO N/A
- NPCE N/A
- Revenue Growth
- HIO N/A
- NPCE 22.05
- 52 Week Low
- HIO $3.52
- NPCE $5.45
- 52 Week High
- HIO $4.03
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- HIO 58.50
- NPCE 30.70
- Support Level
- HIO $3.97
- NPCE $8.97
- Resistance Level
- HIO $3.94
- NPCE $10.58
- Average True Range (ATR)
- HIO 0.03
- NPCE 0.52
- MACD
- HIO -0.00
- NPCE -0.03
- Stochastic Oscillator
- HIO 72.22
- NPCE 9.41
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.